MA41770A - Composition injectable de ricobendazole - Google Patents

Composition injectable de ricobendazole

Info

Publication number
MA41770A
MA41770A MA041770A MA41770A MA41770A MA 41770 A MA41770 A MA 41770A MA 041770 A MA041770 A MA 041770A MA 41770 A MA41770 A MA 41770A MA 41770 A MA41770 A MA 41770A
Authority
MA
Morocco
Prior art keywords
ricobendazole
injectable composition
injectable
composition
ricobendazole injectable
Prior art date
Application number
MA041770A
Other languages
English (en)
Inventor
Mustafa Pacali
Vildan Tombayoglu
Ali Türkyilmaz
Gülay Yelken
Original Assignee
Verano Ilac Sanayi Ve Ticaret A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verano Ilac Sanayi Ve Ticaret A S filed Critical Verano Ilac Sanayi Ve Ticaret A S
Publication of MA41770A publication Critical patent/MA41770A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA041770A 2015-12-08 2016-12-07 Composition injectable de ricobendazole MA41770A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201515599 2015-12-08

Publications (1)

Publication Number Publication Date
MA41770A true MA41770A (fr) 2021-04-28

Family

ID=57530532

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041770A MA41770A (fr) 2015-12-08 2016-12-07 Composition injectable de ricobendazole

Country Status (3)

Country Link
EP (1) EP3178479A1 (fr)
MA (1) MA41770A (fr)
WO (1) WO2017097855A1 (fr)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB417715A (en) * 1932-12-29 1934-10-01 Ig Farbenindustrie Ag Improvements in the manufacture and production of pharmaceutical preparations
US3915986A (en) 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
US4076828A (en) 1977-02-17 1978-02-28 E. R. Squibb & Sons, Inc. Method of treating helminthiasis by parenteral administration of sulfoxide derivatives of benzimidazoles
NZ186378A (en) * 1977-02-17 1980-09-12 Squibb & Sons Inc Use of sulphoxide derivatives of benzimidazolyl carbamic acid esters for helmithiasis
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
GB9115272D0 (en) * 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
CA2163455A1 (fr) 1993-05-26 1994-12-08 Desmond Ronald Hennessy Compositions antiparasitaires
EP0919231A1 (fr) * 1997-10-15 1999-06-02 Biogenesis, S.A. Composition parasiticide injectable et procédé pour la préparation
RU2153329C2 (ru) * 1998-10-22 2000-07-27 Всероссийский научно-исследовательский институт гельминтологии им. К.И. Скрябина Антигельминтное средство
CN1383821A (zh) * 2001-03-16 2002-12-11 王玉万 一种含丙硫苯咪唑亚砜或其盐类的兽用注射剂
CN1575794A (zh) * 2003-07-10 2005-02-09 王玉万 含丙硫咪唑亚砜的液体制剂
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
CN102293739A (zh) * 2010-06-22 2011-12-28 崔增学 一种盐酸丙硫咪唑亚砜注射液的制备方法
CN103550149A (zh) * 2013-10-30 2014-02-05 游锡火 含抗寄生虫药物长效注射剂的制备技术
CN104644548B (zh) * 2013-11-22 2018-09-18 北京康辰药业股份有限公司 卵磷脂作为紫杉醇及其衍生物注射剂药物组合及应用
CN103721260A (zh) * 2014-01-08 2014-04-16 王玉万 含抗寄生虫药/聚乙二醇载药微粒的油质注射剂

Also Published As

Publication number Publication date
WO2017097855A1 (fr) 2017-06-15
EP3178479A1 (fr) 2017-06-14

Similar Documents

Publication Publication Date Title
EP3493800A4 (fr) Composition decannabis
DK3361870T3 (da) Fungicidsammensætninger
EP3339331A4 (fr) Composition
EP3398996A4 (fr) Composition
MA41976A (fr) Composition lubrifiante ultra-fluide
DK3416996T3 (da) Hærdelig sammensætning
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3116953T3 (da) Bitumensammensætning
FR3024363B1 (fr) Composition thermogelifiable
DK3250182T3 (da) Dispergible sammensætninger
EP3334726A4 (fr) Compositions de plinabuline
DK3528902T3 (da) Ringegelsammensætning
EP3430073A4 (fr) Composition de polyaryléthercétone
EP3395887C0 (fr) Composition de caoutchouc fluoré
DK3322295T3 (da) Sammensætning
DK3397734T3 (da) Brændstofsammensætning
CL2017000639A1 (es) Composición
EP3480228A4 (fr) Composition
DK3331498T3 (da) Nasalsammensætning
DK3316857T3 (da) Multifasiske sammensætninger
EP3556804A4 (fr) Composition
DK3393254T3 (da) Sammensætning
LT3173071T (lt) Maropitanto kompozicija
EP3369418A4 (fr) Composition
EP3312212A4 (fr) Composition durcissable